Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approval

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Texas Instruments shares may move 9.1% on earnings report Hisse Senetleri 0 1
A Earnings call transcript: Cohort posts record H2 2026 results, shares slip Hisse Senetleri 0 2
A Earnings call transcript: CDON Group posts q2 2026 growth, shares fall premarket Hisse Senetleri 0 1
A Celcuity prices $500M convertible notes offering due 2032 Hisse Senetleri 0 24
A Celcuity reports positive phase 3 trial results for gedatolisib Hisse Senetleri 0 16
A Celcuity at Leerink Conference: Promising Breast Cancer Drug Results Hisse Senetleri 0 33
A Form 144 Celcuity Inc. For: 27 January Hisse Senetleri 0 71
A Jefferies raises Celcuity stock price target to $134 on positive trial outlook Hisse Senetleri 0 34

Benzer konular

Üst